Cardiology Point of Care Diagnostics
Products, players & outlook to 2017

Cardiology Point of Care Diagnostics Products, players & outlook to 2017

A comprehensive global market report on this high-growth sector

Description

A comprehensive global market report on this high-growth sector

The POC cardiology diagnostics market was worth over US$2 billion in 2011 and rose by 9% compared with 2010. This was driven by a growing interest in the adoption of POC technologies by both healthcare providers and patients at home, as well as the introduction of new products that enable POC testing for more applications, enhance ease-of-use and improve on current products.

POC testing can offer clear benefits over laboratory testing. As it is conducted in the presence of or near the patient, results are obtained quickly, enabling healthcare providers to act swiftly to emergencies such as heart attack and provide a diagnosis while the patient is still in the healthcare facility, speeding treatment and reducing visits to the doctor. For patients, self-testing helps users control their condition, reducing the chance of complications and improving health, while lowering the time and cost of treating complications, and the need for patients to regularly see their doctor.

Clinical acceptance remains an obstacle

This is a key issue. Healthcare providers need evidence that POC diagnostics provide lab-quality results and benefits in terms of clinical-usefulness, convenience and cost in order to adopt them. Unsurprisingly, concerns have been raised by laboratory professionals about the decentralisation of hospital testing and by doctors about patient and consumer self-testing. In both cases, there is concern that the use of POC products by less skilled users may result in inaccurate diagnoses, leading to resistance to the changes needed for POC products to be widely implemented.
Overcoming these issues will be critical to the POC diagnostic sector if it is to realise its full potential - at present, adoption and usage rates vary widely, and there remains much untapped potential in the worldwide market.

Innovation is making an impact

There is currently much innovation in the market. Products that enable multi-parameter diagnostics using technologies such as microfluidics are a major focus, as are products for personalised medicine. For example, the first POC DNA analysis system, Spartan Bioscience?s RX CYP2C19, has European approval to help identify patients with impaired metabolism to the popular anti-blood clotting medication, clopidogrel.

This new September 2012 report delivers a complete and insightful analysis
This new 130-page highly detailed report - Volume 1 of a 4-volume study of the whole IVD sector to be published this autumn/winter - provides executives with a complete understanding of the issues which are shaping the market and how they will affect its commercial development.

Get the best from your investment! Pdf or print formats and the brilliant Espicom Interactive included at no extra cost!
Customers can choose print or pdf format but all get access via Espicom Interactive. Customers will really benefit from accessing this report?s rich content through Espicom Interactive by...
Accessing daily-reviewed company reports, updates and news
Intuitively cross file searching and getting fast results
Saving time and effort by extracting data with instant one click export to MS ExcelTM and MS PowerPointTM
Using the machine translation tool to translate text into 9 leading languages
Easily building their own reports from all the content

More Information...

Covering all major POC cardiology testing technologies

• Coagulation
• Platelet Function
• Cardiac Markers
• Cholesterol
• Companion Diagnostics

Products for all user groups

Physician Office

Emergency Room/A&E

Home Testing

Use this report to...

• Understand the trends which are shaping the sector's operation
• Identify which sectors offer the greatest growth potential over the next 5 years
• Highlight the emerging companies in the industry with novel technology
• Evaluate the competitive landscape and identify the companies to watch
• Know who?s striking strategic and tactical partnerships
• Monitor M&A activity and the changing competitive landscape
• Identify the leading products

Focus on... Mergers & Acquisitions

M&A activity has increased significantly in recent years and this industry consolidation is changing the dynamics of the market, potentially to the detriment of smaller companies. In particular, Alere has reinforced its industry dominance with several key acquisitions in the past five years, including HemoSense, Cholestech and Biosite. In 2011, it acquired Axis-Shield, a company with POC sales of nearly ?50 million in 2010, and Medical Automation Systems, the market leader in POC IT connectivity solutions.

• MARKET OVERVIEW
• EXECUTIVE SUMMARY
• INTRODUCTION
• POC Cardiovascular POC
• The Role Of POC Testing in Cardiovascular Care
• Customers of POC Cardiovascular Diagnostic Products
• POC Cardiovascular Technologies by Customer Segment
• Regulatory and Reimbursement Environment
• CLIA Waiver
• CURRENT MARKET DYNAMICS
• Fig.1: POC Diagnostics in Relation to the IVD Market,
• Fig.2: Percentage of POC Diagnostics Market by Product,
• Regional Perspective
• Fig.3: Professional POC Diagnostics Market by Region,
• POC Cardiovascular Testing Market
• POC Cardiovascular Diagnostics Market by Product Type, 2007-2011 (US$ million)
• Fig.4: Cardiac POC Testing Market by Product,
• GROWTH DRIVERS, RESTRAINTS AND FUTURE OPPORTUNITIES
• The Burden of Cardiovascular Disease
• POC Diagnostics and the Economy
• POC Diagnostics as a Disruptive Technology
• Clinical Utility and Accuracy
• Connectivity
• Emerging Technologies
• Companion Diagnostics
• Lab-on-a-Chip Devices and Microfluidics
• Summary: Market Drivers, Restraints and Opportunities
• COMPETITIVE LANDSCAPE
• Market Leaders for Cardiovascular POC Testing Products
• Select POC Diagnostics Companies' Sales, 2007-2011 (US$ million)
• Merger and Acquisition Activity
• Key POC Diagnostics Mergers and Acquisitions,
• FUTURE MARKET PROSPECTS
• POC Cardiovascular Testing Market by Product Type, 2011-2017E (US$ million)
• POC Cardiovascular Testing Market by Product Growth, 2008-2017E (%)
• POC CARDIOVASCULAR PRODUCTS AND TECHNOLOGIES
• POC COAGULATION TESTING
• POC Coagulation Testing Market Dynamics
• Fig.5: Global POC Coagulation Market, 2007-2017E (US$ million)
• The Impact of New-Generation Anticoagulants
• Self-Monitoring Products
• CoaguSense's CoaguSense PT/INR Monitoring System
• Alere's INRatio2 System
• International Technidyne Corporation's ProTime System
• ProTime Microcoagulation System
• Roche's CoaguChek XS
• Professional Use Products
• Abbott's i-STAT System
• i-STAT Cartridges
• Alere's Axis-Shield Products
• Helena Laboratories' Cascade POC System
• Helena Laboratories' Actalyke & MAX-ACT
• Medtronic's ACT Plus Automated Coagulation Timer System
• Instrumentation Laboratory's GEM PCL Plus
• ITC's Hemochron Whole Blood Coagulation System
• Hemochron Signature Elite and Hemochron Signature Plus Microcoagulation System
• Hemochron Response
• Radiometer's AQT90 FLEX Immunoassay Analyser
• Roche's CoaguChek Systems
• CoaguChek XS Pro
• CoaguChek XS Plus
• CoaguChek XS
• CoaguChek Link
• Products in Development
• Bio-AMD's COAG
• Siemens/Universal Biosensors' POC Coagulation Tests
• Surgical Coagulation and Haemostasis Management
• Akers Biosciences' PIFA Heparin/PF4 and PIFA PLUSS Rapid Assays
• Haemonetics' TEG Thrombelastograph Hemostasis Analy